期刊
VACCINES
卷 10, 期 6, 页码 -出版社
MDPI
DOI: 10.3390/vaccines10060839
关键词
Trueperella pyogenes; DNA vaccine; recombinant proteins; heterologous prime-boost; pyolysin
资金
- Talent Introduction of Project of Chengdu University [2081918021]
- Sichuan Science and Technology Program [2018HH0007]
- Science and Technology Bureau Program of Chengdu Municipal Government [2016-XT00-00023-GX]
This study developed a heterologous prime-boost vaccination scheme utilizing a DNA vaccine and a subunit vaccine to enhance immune responses against T. pyogenes in mice. The results showed that this vaccination strategy reduced bacterial burdens and boosted humoral and cellular immune responses, effectively protecting the mice from T. pyogenes infection.
Trueperella pyogenes (T. pyogenes) is a crucial opportunistic pathogen normally causing mastitis, abscesses and pneumonia in economically important ruminants. Although only one commercial vaccine of T. pyogenes is currently obtainable, its immunoprotective effect is limited. Pyolysin (PLO) is the most predominant virulence factor highly expressed in T. pyogenes and is an excellent target for the development of novel vaccines against T. pyogenes. In this study, we designed a heterologous prime-boost vaccination scheme combining a DNA vaccine pVAX1-PLO and a subunit vaccine His-PLO to maximize host responses in mice. Humoral and cellular immune responses and protective effects were evaluated in mice to compare the immunogenicity induced by different immunization schemes. Compared to the PBS-control group, in vivo immunization results showed that better immune responses of mice immunized with the pVAX1-PLO plasmids and His-PLO proteins were induced. The residual bacterial burdens from the liver and peritoneal fluid were remarkably decreased in the immunized mice compared with the PBS group. Notably, the heterologous prime-boost vaccination groups significantly enhanced host humoral and cellular immune responses and protected mice from different virulent T. pyogenes strains infection. Conclusively, this study provides a favorable strategy for the further development of next-generation vaccines against T. pyogenes infections.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据